82 results
8-K
EX-99.1
MDGL
Madrigal Pharmaceuticals Inc
7 May 24
Madrigal Pharmaceuticals Reports First-Quarter 2024 Financial Results and Provides Corporate Updates
7:06am
launch, where our expert team is partnering with the NASH community to establish treatment pathways for patients, laying the groundwork for our long-term
8-K
EX-99.1
MDGL
Madrigal Pharmaceuticals Inc
14 Mar 24
Regulation FD Disclosure
6:47pm
have been waiting many years for the first approved therapy. I believe this approval milestone will bring new energy and momentum to the NASH community … of the MAESTRO studies, commented, “The approval of the first medication for NASH is a true game-changer for healthcare providers, the research community
8-K
EX-99.2
MDGL
Madrigal Pharmaceuticals Inc
14 Mar 24
Regulation FD Disclosure
6:47pm
, Becky Taub and 5 Q&A Mardi Dier Chief Financial Officer Madrigal Pharmaceuticals
Terri’s Story Terri is a patient leader in the NASH community Her
8-K
EX-99.1
uh7s18lj cng
8 Aug 23
Madrigal Pharmaceuticals Provides Corporate Updates and Reports Second Quarter 2023 Financial Results
8:00am
8-K
EX-99.1
yap6kgqe
24 Feb 22
Madrigal Pharmaceuticals Provides Business and Clinical Updates and Reports 2021 Fourth Quarter and Full Year Financial Results
8:01am
424B5
4c5pay8
7 Jun 18
Prospectus supplement for primary offering
4:35pm